241 Stock Overview
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Alibaba Health Information Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.65 |
| 52 Week High | HK$10.14 |
| 52 Week Low | HK$3.00 |
| Beta | 0.99 |
| 1 Month Change | -17.11% |
| 3 Month Change | -16.96% |
| 1 Year Change | 18.93% |
| 3 Year Change | -76.06% |
| 5 Year Change | -33.29% |
| Change since IPO | 263.28% |
Recent News & Updates
Recent updates
Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Jun 22
Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?
Dec 01Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Oct 15Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Aug 12Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price
Jun 25These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts
May 30Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%
May 27The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising
Mar 23Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?
Mar 05How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?
Feb 15Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 31
If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today
Dec 31Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 16Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?
Dec 01Shareholder Returns
| 241 | HK Consumer Retailing | HK Market | |
|---|---|---|---|
| 7D | -5.1% | -5.8% | -5.2% |
| 1Y | 18.9% | -2.1% | -9.8% |
Return vs Industry: 241 exceeded the Hong Kong Consumer Retailing industry which returned 2.2% over the past year.
Return vs Market: 241 exceeded the Hong Kong Market which returned -8.3% over the past year.
Price Volatility
| 241 volatility | |
|---|---|
| 241 Average Weekly Movement | 7.1% |
| Consumer Retailing Industry Average Movement | 7.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in HK Market | 12.8% |
| 10% least volatile stocks in HK Market | 3.1% |
Stable Share Price: 241 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 241's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,560 | Shunyan Zhu | https://www.alihealth.cn |
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and TCM through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, Gaode, DingTalk, and Quark.
Alibaba Health Information Technology Limited Fundamentals Summary
| 241 fundamental statistics | |
|---|---|
| Market Cap | HK$62.83b |
| Earnings (TTM) | HK$590.06m |
| Revenue (TTM) | HK$29.61b |
106.5x
P/E Ratio2.1x
P/S RatioIs 241 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 241 income statement (TTM) | |
|---|---|
| Revenue | CN¥26.76b |
| Cost of Revenue | CN¥21.06b |
| Gross Profit | CN¥5.70b |
| Other Expenses | CN¥5.17b |
| Earnings | CN¥533.41m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.039 |
| Gross Margin | 21.30% |
| Net Profit Margin | 1.99% |
| Debt/Equity Ratio | 0% |
How did 241 perform over the long term?
See historical performance and comparison